Knowledge of the Pharmacology of Antidepressants and Antipsychotics Yields Results Comparable With Pharmacogenetic Testing

被引:10
|
作者
Macaluso, Matthew [1 ]
Preskorn, Sheldon H. [1 ]
机构
[1] Univ Kansas, Sch Med, Wichita, KS 67214 USA
关键词
pharmacogenetic tests; drug metabolism; cytochrome P450 enzymes; antidepressants; antipsychotics; blood levels; GeneSight test; MAJOR DEPRESSIVE DISORDER;
D O I
10.1097/PRA.0000000000000345
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Several companies offer pharmacogenetic testing for psychiatry on the basis of the claim that the outcome of drug selection is better when guided by such testing than when such testing is not used. This column examines the results of the GeneSight Psychotropic Test which groups various antidepressants and antipsychotics into 3 bins: green (use as directed), yellow (use with caution), and red (use with increased caution and more frequent monitoring). The authors examined how frequently the same drugs appeared in these different bins in 19 patients. They found that of the 22 antidepressants evaluated, 2 were virtually always (>90%) in the green bin: desvenlafaxine and levomilnacipran; and 8 were almost never (10.5%) in the green bin: citalopram, duloxetine, escitalopram, fluoxetine, fluvoxamine, mirtazapine, paroxetine, and sertraline. Of the 16 antipsychotics evaluated, they found that 4 were virtually always (>90%) in the green bin: asenapine, lurasidone, paliperidone, and ziprasidone; and 2 were almost never (10.5%) in the green bin: chlorpromazine and thioridazine. What was common among those drugs almost always in the green bin versus those almost never in the green bin were newer versus older marketed drugs and those not dependent versus dependent on oxidative metabolism for their clearance. The authors concluded that the results of this pharmacogenetic testing could be predicted on the basis of knowledge of the pharmacology of the drugs, particularly whether their clearance was dependent on oxidative drug metabolism.
引用
收藏
页码:416 / 419
页数:4
相关论文
共 50 条
  • [21] Measuring knowledge and attitudes towards the utilization of pharmacogenetic testing among physicians
    Muflih, Suhaib
    Bleidt, Barry A.
    Lafferty, Lynn
    Shawaqfeh, Mohammad S.
    Alvarez, Goar
    JOURNAL OF PHARMACEUTICAL HEALTH SERVICES RESEARCH, 2019, 10 (02) : 227 - 234
  • [23] Exploring perceptions, knowledge, and attitudes regarding pharmacogenetic testing in the medically underserved
    Gawronski, Brian E.
    Cicali, Emily J.
    McDonough, Caitrin W.
    Cottler, Linda B.
    Duarte, Julio D.
    FRONTIERS IN GENETICS, 2023, 13
  • [24] Efficacy Testing of a Novel Retinoid in Gottingen Mini-pig Skin Organ Culture Yields Comparable Results to That in Intact Animal.
    Dame, M. K.
    Paruchuri, T.
    DaSilva, M.
    Bhagavathula, N.
    Ridder, W.
    Varani, J.
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2009, 45 : S43 - S44
  • [25] A response to “Effect of CYP2D6 pharmacogenetic phenotype and phenoconversion on serum concentrations of antidepressants and antipsychotics: a retrospective cohort study”
    Xiang Shang
    International Journal of Clinical Pharmacy, 2023, 45 : 1307 - 1308
  • [26] A response to "Effect of CYP2D6 pharmacogenetic phenotype and phenoconversion on serum concentrations of antidepressants and antipsychotics: a retrospective cohort study"
    Shang, Xiang
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2023, 45 (05) : 1307 - 1308
  • [27] DOCUMENTATION OF RESULTS AND MEDICATION PRESCRIBING AFTER COMBINATORIAL PSYCHIATRIC PHARMACOGENETIC TESTING
    Loftus, J.
    Levy, H.
    Stevenson, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 : S23 - S23
  • [28] Pharmacogenetic Testing Knowledge and Attitudes among Pediatric Psychiatrists and Pediatricians in Alberta, Canada
    Jessel, Chaten D.
    Al Maruf, Abdullah
    Oomen, Anita
    Arnold, Paul D.
    Bousman, Chad A.
    JOURNAL OF THE CANADIAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2022, 31 (01) : 18 - 27
  • [29] Psychiatric mental health nurse practitioner student knowledge and perceptions of pharmacogenetic testing
    Kaltenrieder, Corrina M.
    White, Michelle Marie
    Cheek, Dennis J.
    FRONTIERS IN GENETICS, 2023, 14
  • [30] Documentation of results and medication prescribing after combinatorial psychiatric pharmacogenetic testing: A case for discrete results
    Loftus, John
    Levy, Howard P.
    Stevenson, James M.
    GENETICS IN MEDICINE, 2024, 26 (04)